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Abstract
Aims/hypothesis In an Indian birth cohort, higher maternal
homocysteine concentration in pregnancy was associated with
lower birthweight of the offspring. Lower maternal vitamin
B12 and higher folate concentrations were associated with
higher offspring insulin resistance. Disordered one-carbon
metabolism during early development may increase later met-
abolic risk. We explored these associations in another birth
cohort in India at three age points.
Methods We measured plasma vitamin B12, folate and ho-
mocysteine concentrations at 30±2 weeks’ gestation in 654
women who delivered at one hospital. Neonatal anthropome-
try was recorded, and the children’s glucose and insulin con-
centrations were measured at 5, 9.5 and 13.5 years of age.
Insulin resistance was estimated using HOMA of insulin
resistance (HOMA-IR).
Results Maternal homocysteine concentrations were inverse-
ly associated with all neonatal anthropometric measurements
(p <0.05), and positively associated with glucose concentra-
tions in the children at 5 (30 min; p =0.007) and 9.5 years of
age (120 min; p =0.02). Higher maternal folate concentrations
were associated with higher HOMA-IR in the children at 9.5
(p =0.03) and 13.5 years of age (p =0.03). Maternal vitamin
B12 concentrations were unrelated to offspring outcomes.
Conclusions/interpretation Maternal vitamin B12 status did
not predict insulin resistance in our cohort. However, associ-
ations of maternal homocysteine and folate concentrations
with birth size, and with childhood insulin resistance and
glycaemia in the offspring, suggest a role for nutritionally
driven disturbances in one-carbon metabolism in fetal pro-
gramming of diabetes.
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Nutrition during fetal development has long-term health con-
sequences [1]. Fetal nutrition is influenced by maternal nutri-
tional status, and experiments in animal models have shown
that both maternal undernutrition and overnutrition can cause
obesity, insulin resistance and diabetes in the adult offspring
[2, 3]. Vitamin B12 and folate are important nutrients required
for nucleic acid synthesis, DNA methylation and cellular
growth and differentiation. Several studies have reported that
low maternal folate and vitamin B12 concentrations and high
homocysteine concentrations (a marker of deranged one-
carbon metabolism) predict smaller newborn size [4–7].
However, data linking maternal diet and nutrient status to
long-term offspring outcomes in humans are limited.
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Recently it was observed in a rural population in Pune,
India, that low maternal vitamin B12 concentrations and high
erythrocyte folate concentrations during pregnancy were asso-
ciated with higher insulin resistance in 6-year-old offspring [8].
In another study, among children in Nepal born to mothers who
took part in a randomised controlled trial of micronutrients in
pregnancy, maternal vitamin B12 deficiency at baseline was
associated with higher offspring insulin resistance at the age of
6–8 years [9], though there was no apparent folate effect.
The Parthenon Study in Mysore, India, is an observational
study to investigate maternal and fetal factors related to off-
spring cardiovascular and diabetes risk [10, 11]. We have
previously shown that lowmaternal vitamin B12 status during
pregnancy was related to a higher incidence of gestational
diabetes mellitus (GDM) [12]. Maternal GDM was a major
predictor of the children’s adiposity and insulin resistance at
9.5 years of age [11]. In the current analysis we aimed to
replicate the Pune analysis, to examine whether low maternal
vitamin B12 and high plasma folate concentrations predicted
higher insulin resistance and other cardiometabolic risk fac-
tors in children. Our serial follow-up allowed us to investigate
these associations at 5, 9.5 and 13.5 years of age.
Methods
Study population During 1997–1998, 830 women booking
consecutively into the antenatal clinic of the CSI Holdsworth
Memorial Hospital (HMH) in Mysore, India, and matching
our eligibility criteria (<32 weeks’ gestation at recruitment, no
known history of diabetes, intention to deliver at HMH, sin-
gleton pregnancy) had a 100 g, 3 h OGTT at 30±2 weeks’
gestation (Fig. 1) [10]. GDM was diagnosed in 49 women of
the 785 women who completed an OGTT (6.2%) using the
Carpenter and Coustan criteria [13].
Vitamin B12 and folic acid supplements It was routine for
general practitioners and obstetricians to prescribe folic acid
and/or multivitamin supplements to women throughout preg-
nancy. Supplement use was recorded at recruitment, but not
subsequently, and no information was therefore available on
their use at 30 weeks’ gestation, when blood samples were
taken, or at term.
Follow-up of the offspring At HMH, 663 women delivered
live babies without major congenital anomalies. The babies
were measured for head and mid–upper arm circumference
(MUAC), weight, length, and subscapular and triceps skinfold
thicknesses within 72 h of birth as described before [10].
On further follow-up, 25 children had died and eight had
major medical conditions. Of the remaining children, detailed
anthropometry was performed and percentage body fat (fat%)
was measured using bioimpedance in all available children at
5 year (n =585), 9.5 year (n =539) and 13.5 year follow-ups
(n =545), and systolic and diastolic BP were measured as
described elsewhere [11, 14]. Pubertal status was assessed
using Tanner’s method at 9.5 and 13.5 years of age [15], and
was classified as the stage of breast development (in girls) or
genital development (in boys). The socioeconomic status
(SES) of the family was determined at 9.5 years using the
Standard of Living Index designed by the National Family
Health Survey-2 [16]. Glucose, insulin and fasting lipid con-
centrations weremeasured at 5 and 9.5 years from a 2 hOGTT
[11, 14].
At 13.5 years of age, glucose, insulin and lipid concentra-
tions were measured using fasting blood samples. The labo-
ratory assays were carried out at the Diabetes Unit, KEM
Hospital, Pune, India, whose laboratory is a member of the
UK National External Quality Assessment Service (NEQAS)
quality control programme for insulin assays. Laboratory staff
were blind to the identity of the samples and the vitamin B12
and folate status of the mothers. Plasma glucose and lipid
concentrations were measured by standard enzymatic
methods (Hitachi-902; Roche Diagnostics, Mannheim,
Germany). Insulin was measured by ELISA (Mercodia
Ultrasensitive; Mercodia, Uppsala, Sweden). Inter- and intra-
assay CV was <7.0%. Insulin resistance was estimated using
the HOMA of insulin resistance (HOMA-IR) at all three time
points [17].
Vitamin B12, folate and homocysteine measurements Maternal
vitamin B12, folate and homocysteine concentrations were
analysed using plasma samples stored at −80°C for 8 years;
adequate samples were available for 654 mothers who were
included in the analysis. Measurements were carried out at the
Diabetes Unit, KEM Hospital, Pune, using microbiological
assays for vitamin B12 and folate and fluorescence
polarisation immunoassay (Abbott Laboratories, Abbott
Park, IL, USA) for homocysteine [18–20]. The children’s
vitamin B12 and folate concentrations were measured at
9.5 years (n =528), and homocysteine concentrations were
analysed at 5 years of age (n =567). Intra- and inter-assay
CV were <8% for these assays.
Maternal vitamin B12 deficiency was defined as a
concentration <150 pmol/l, and folate deficiency a con-
centration <7 nmol/l. Maternal hyperhomocysteinaemia
was defined as a homocysteine concentration >10 μmol/l.
These cut-offs were based on the levels used for adult popu-
lations elsewhere [21–23].
The HMH research ethics committee approved the study.
Informed written consent was obtained from the parents and
assent from the children.
Statistical methods The distributions of the children’s
skinfold thickness, insulin concentrations, HOMA-IR, and
vitamin B12 and homocysteine concentrations were skewed;
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these data were natural log-transformed (ln). Differences be-
tween groups were analysed using independent t tests. To
facilitate comparison of associations, exposure and outcome
variables were converted into SD scores (SDS). The data
represent SD change in offspring outcome per SD change in
maternal nutrient status. Associations between maternal vita-
min B12, folate and homocysteine concentrations and off-
spring outcomes were examined using multivariate linear
regression, adjusting for gestational age (for birth variables)
or current age (for childhood variables) and sex. Additional
adjustments were made for maternal parity, religion, BMI,
GDM and SES, and the children’s vitamin B12, folate, current
BMI and pubertal stage where relevant; p values of <0.05
were considered significant. All analyses were performed
using IBM SPSS statistics version 19 (IBM, Armonk, NY,
USA).
Results
Characteristics of the 654 mothers with information on gesta-
tional nutrient status, and their children at birth and at 5 (n =
578), 9.5 (n =533) and 13.5 years of age (n =539) are present-
ed in Table 1. Vitamin B12 deficiency was present in 41.4% of
the women, while only 4% had folate deficiency and
hyperhomocysteinaemia. The prevalence of vitamin B12 de-
ficiency was highest among Hindu women (n =183, 49.1%,
median vitamin B12 151.0 pmol/l; Muslim women: n =67,
29.8%, 181.0 pmol/l; others: n =21, 37.5%, 180.0 pmol/l).
Plasma folate concentrations were lowest among Muslim
women (25.8 nmol/l; Hindu women: 40.0 mmol/l; others:
45.7 nmol/l). Homocysteine concentrations were highest
among Hindu women (6.3 μmol/l; Muslim women:
5.6 μmol/l; others: 5.6 μmol/l). Maternal homocysteine con-
centrations were inversely associated with both vitamin B12
(r =−0.15, p <0.001) and plasma folate concentrations
(r =−0.24, p <0.001). Vitamin B12 concentrations were unre-
lated to SES or parity. Higher SES (p <0.001) and lower parity
(p <0.001) were associated with higher plasma folate concen-
trations. Supplement use at recruitment (mean [SD] 20 [6]
weeks’ gestation) was not significantly associated with vita-
min B12 and folate concentrations at 30±2 weeks’ gestation.
At 9.5 years of age, vitamin B12 deficiency was present in
2.7% of children, and folate deficiency in only one child.
Offspring vitamin B12 (r =0.17, p <0.001) and folate concen-
trations (r =0.19, p <0.001) were positively correlated with
maternal vitamin B12 and folate concentrations, respectively.
Offspring homocysteine concentrations at 5 years were posi-
tively correlated with maternal homocysteine concentrations
(r =0.14, p <0.001). Higher maternal folate concentrations
were associated with more advanced pubertal stage in the
offspring at 13.5 years of age (p =0.04). There was no asso-
ciation between maternal vitamin B12 and homocysteine con-
centrations and offspring pubertal status.
830 women participated 
OGTT, anthropometry at 30±2 weeks’ gestation (49 GDM)
vitamin B12, folate, homocysteine
674 births at HMH 
663 live births without major anomalies (41 GDM)
anthropometry within 72 h of birth
654 babies included at birth
533 children included at 9.5 
years 
Maternal nutrient status not 
available (n=9)
Did not deliver at HMH, 
no details (n=156)
11 excluded
(7 still births + 4 major anomalies)










Fig. 1 Flow chart of the study
participants
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Maternal nutrients and neonatal anthropometry Newborn
weight and MUAC tended to increase with maternal plasma
folate concentrations, though these associations were marked-
ly attenuated and none were statistically significant following
adjustment for maternal covariates (Table 2). Higher maternal
homocysteine concentrations were associated with smaller
neonatal weight, MUAC and skinfold measurements
(Table 2). The prevalence of low birthweight (32.0% vs
19.1%; p =0.1) and preterm (12.0% vs 7.6%; p =0.4) births
tended to be higher among those born to mothers with
hyperhomocysteinaemia compared with babies born to
mothers with normal homocysteine levels. Maternal vitamin
B12 concentrations were unrelated to anthropometry at birth
(data not shown).
Maternal nutrients and children’s anthropometry There were
positive associations between maternal folate concentrations
and offspring weight, height and MUAC at 5 years of age.
These associations were not significant after adjusting for
maternal covariates and offspring nutrient status (Table 3).
Maternal folate concentrations were positively associated with
the children’s anthropometric measurements at 9.5 and
13.5 years, except for subscapular skinfold thickness and
fat% (Table 3). The strength of these associations diminished
after full adjustment, but remained statistically significant for
height (Table 3). There were no associations of maternal
homocysteine or vitamin B12 concentrations with the chil-
dren’s anthropometry.
Maternal nutrients and children’s insulin resistance and risk
factors At 5 years of age, after adjusting for maternal and
offspring covariates including current BMI, maternal folate
concentrations were positively associated with fasting glucose
concentrations in their offspring (Table 3). Maternal folate
concentrations were positively associated with fasting insulin
and HOMA-IR in the offspring at both 9.5 and 13.5 years of
age, and this association remained significant after full adjust-
ment including maternal vitamin B12 and children’s current
BMI and pubertal stage (Table 3). There were also positive
associations between maternal folate and offspring 30 min
insulin concentrations at 9.5 years of age; however, this
association became non-significant after full adjustment
(Table 3). There were no differences in the associations
between maternal plasma folate and offspring outcomes
between children whose mothers had low or normal
vitamin B12 concentrations, and there were no signifi-
cant interactions between maternal folate and vitamin
B12 deficiency (electronic supplementary material
[ESM] Table 1).
Higher maternal homocysteine concentrations were asso-
ciated with higher 30 min glucose and insulin concentrations
at 5 years of age (Table 4). Higher maternal homocysteine
concentrations were associated with higher 120 min glucose
concentrations in the children at 9.5 years (Table 4). These
associations remained significant after further adjusting for
birthweight. There was also a borderline positive association
between maternal homocysteine and HOMA-IR at 9.5 years
of age. There was no association between maternal homocys-
teine and offspring HOMA-IR at 13.5 years of age.




Age, years 654 24.0 (20.0, 26.0)
BMI, kg/m2 654 23.3 (21.0, 26.0)
Vitamin B12, pmol/l 654 163.5 (123.0, 224.0)
B12 deficiency, n (%) 654 271 (41.4)
Plasma folate, nmol/l 654 35.4 (17.9, 51.2)
Folate deficiency, n (%) 654 26 (4.0)
Homocysteine, μmol/l 648 6.0 (5.1, 7.0)
Hyperhomocysteinaemia, n (%) 648 25 (3.9)
Offspring
Birth
Birthweight, kg 654 2.855 (2.575, 3.165)
Crown–heel length, cm 653 48.7 (47.5, 50.1)
Birthweight SDS 654 −0.9 (−1.6, −0.3)
Birth length SDS 653 −0.5 (−1.1, 0.3)
Head circumference, cm 653 33.9 (32.9, 34.7)
MUAC, cm 651 10.3 (9.6, 10.9)
Subscapular skinfold thickness, mm 651 4.3 (3.9, 4.9)
5 years
Height, cm 578 105.6 (102.8, 108.3)
BMI, kg/m2 578 13.4 (12.9, 14.2)
Height SDS 578 −0.9 (−1.5, −0.3)
BMI SDS 578 −1.4 (−1.9, −0.7)
Insulin resistance (HOMA-IR) 572 0.7 (0.5, 1.1)
Insulin increment 566 26.7 (14.8, 41.9)
9.5 years
Height, cm 533 130.5 (127.0, 134.4)
BMI, kg/m2 533 14.3 (13.4, 15.5)
Height SDS 533 −0.8 (−1.3, −0.2)
BMI SDS 533 −1.3 (−2.0, −0.4 )
Insulin resistance (HOMA-IR) 525 0.8 (0.5, 1.2)
Vitamin B12, pmol /l 522 312.5 (249.8, 404.8)
Plasma folate, nmol /l 522 24.0 (18.0, 35.0)
13.5 years
Height, cm 539 153.4 (148.9, 158.2)
BMI, kg/m2 539 17.0 (15.5, 19.3)
Height SDS 539 −0.7 (−1.4, −0.1)
BMI SDS 539 −0.8 (−1.8, 0.06)
Insulin resistance (HOMA-IR) 528 1.5 (1.0, 2.0)
Values given are median (interquartile range) or n (%)
SDSs are based on WHO growth standards
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Maternal vitamin B12 concentrations were not associated
with any of the offspring risk factors (Table 4). Maternal
folate, vitamin B12 and homocysteine concentrations were
not associated with offspring blood pressure or fasting lipid
concentrations (data not shown).
All associations remained unchanged after excluding the
offspring of GDM mothers.
Discussion
In this well-characterised cohort of urban Indian children,
higher maternal homocysteine concentration was associated
with smaller size at birth, and higher postload glucose con-
centrations at 5 and 9.5 years. Higher maternal folate concen-
tration was associated with higher insulin resistance (HOMA-
IR) at 9.5 and 13.5 years. There were no associations of
maternal vitamin B12 concentration with size at birth or with
insulin resistance and other cardiometabolic risk markers.
Earlier studies have observed a high prevalence of vitamin
B12 deficiency and elevated levels of homocysteine but not
folate deficiency among Indians [4, 8]. Consistent with these
findings, more than 40% of our study women were vitamin
B12-deficient, while only 4% had low serum folate concen-
trations. The homocysteine concentrations were, however,
lower than those reported in other studies in the Indian sub-
continent (Table 5). A recent systematic review and meta-
analysis found that higher maternal homocysteine concentra-
tion in pregnancy is consistently associated with lower
birthweight, in different populations [24]. Overall, it showed
a 31 g reduction in birthweight per SD increase in homocys-
teine, and hyperhomocysteinaemia (>90th percentile) was
associated with an OR of 1.25 (95% CI 1.09, 1.44) for a
small-for-gestational-age baby. Our results are consistent with
Table 2 Mean (SD) anthropometry at birth according to fourths of maternal folate and homocysteine concentrations
Variable n Weight, kg Length, cm Head
circumference, cm




Plasma folate concentration, nmol/l
<17.8 163 2.781 (0.488) 48.3 (2.5) 33.6 (1.6) 10.1 (1.1) 4.4 (3.9, 5.0) 4.0 (3.5, 5.2)
17.9–35.2 163 2.862 (0.472) 48.6 (2.5) 33.7 (1.5) 10.3 (1.0) 4.3 (3.9, 4.9) 4. 1 (3.5, 4.8)
35.3–51.1 164 2.894 (0.492) 48.7 (2.6) 33.7 (1.7) 10.4 (1.0) 4.4 (3.9, 4.9) 4.2 (3.7, 5.7)
>51.1 164 2.900 (0.440) 48.8 (2.0) 33.9 (1.4) 10.3 (1.0) 4.4 (3.9, 4.9) 4.1 (3.6, 4.6)
Model 1












p value 0.08 0.2 0.2 0.04 0.8 0.5
Model 2b












p value 0.7 0.9 0.4 0.6 0.4 0.6
Homocysteine concentration, μmol/l
<5.06 163 2.937 (0.446) 48.7 (2.3) 33.9 (1.4) 10.4 (0.9) 4.5 (3.9, 5.0) 4.2 (3.8, 4.9)
5.07–6.01 165 2.876 (0.417) 48.7 (2.2) 33.8 (1.5) 10.4 (1.0) 4.4 (3.9, 4.9) 4.2 (3.7, 4.8)
6.02–7.04 163 2.814 (0.481) 48.5 (2.7) 33.6 (1.7) 10.1 (1.1) 4.3 (3.9, 4.9) 3.9 (3.5, 4.6)
>7.04 163 2.789 (0.539) 48.4 (2.6) 33. 7 (1.6) 10.1 (1.2) 4.3 (3.7, 5.0) 4.0 (3.5, 4.8)
Model 1












p value 0.001 0.1 0.3 0.002 0.08 0.03
Model 2












p value 0.001 0.06 0.1 <0.001 0.006 0.006
β and p values derived by linear regression using maternal folate and homocysteine concentrations, and newborn measurements as continuous SDS; β
represents SDS change in outcome variable per SDS change in exposure variable
aLog-transformed variables, values given are geometric mean (interquartile range)
Model 1, adjusted for baby’s sex and gestational age
Model 2, model 1 + maternal BMI, GDM status, SES, parity, religion and bvitamin B12
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this, showing a 60 g fall in birthweight per SD of maternal
homocysteine concentration, which was echoed in a reduction
in all birth measurements. We did not find associations be-
tween maternal vitamin B12 or folate status and newborn size.
Evidence from other populations has been inconsistent on this
point, especially for vitamin B12. The Pune study showed no
association between maternal B12 status and birthweight [8],
while another Indian study, from Bangalore, showed a posi-
tive association [4]. Several studies, including the Pune study,
have shown positive associations between maternal folate
status and birthweight [5, 6, 8].
The protective effect of maternal folate repletion against
neural tube defects is well known. This has led to the recom-
mendation for folate supplementation in the preconceptional
period, and, in a number of countries, folate fortification of
staple foods, to achieve wide coverage of mothers in the
crucial early stages of pregnancy [25]. Studies linking mater-
nal folate status with long-term outcomes in the children are,
however, few and are mainly based on observational data [8,
26–28]. In the only data from a randomised controlled trial,
children of women in Nepal who were supplemented with
vitamin A plus folic acid from early gestation had less
microalbuminuria and a lower prevalence of metabolic syn-
drome at 6–8 years than children of mothers supplemented
with vitamin A alone [29]. Interestingly, these reductions in
microalbuminuria and metabolic syndrome were not observed
in children of mothers who received the same dose of folic
acid as part of a multiple micronutrient supplement. In the UK,
observational studies have shown higher bonemineral content
in children of mothers with higher dietary folate intakes [26];
in the Pune (India) study, higher bone mineral content and
density in children of mothers with higher folate status in
pregnancy [27]; and in our study reported here, taller height
and better cognitive function [28] in children of mothers with
higher folate status.
By contrast, the Pune study linked higher maternal folate
status with a potentially adverse outcome: higher childhood
insulin resistance [8]. Our study inMysore has now confirmed
this, and, for the first time, showed that this association tracks
into early adolescence. This is a small effect: a 1 SD higher
maternal folate concentration was associated with a ∼0.09 SD
increase in childhood HOMA-IR at both 9.5 and 13.5 years of
age in our children. In Pune children, there was a similar,
albeit bigger, effect: a 0.18 SD increase in HOMA-IR for a 1
SD increase in erythrocyte folate. In Pune, lower maternal
vitamin B12 status was also associated with higher offspring
insulin resistance, and the highest mean HOMA-IR was in
children of mothers with B12 deficiency and high folate
status. The only other study to examine this question is the
Nepal randomised trial [9]. This trial showed that maternal
vitamin B12 deficiency at baseline was associated with higher
HOMA-IR in the children, but there was no association with
maternal folate status, and no difference in HOMA-IR
between children of mothers who were or were not supple-
mented with folic acid. In Mysore, there was also an associ-
ation between higher maternal homocysteine concentration
and postload glucose concentration in the children. This was
not observed in the Pune study, and it was not investigated in
the Nepal study.
These differences between studies may arise from differ-
ences in maternal micronutrient status and differences in fetal
growth (Table 5). Maternal plasma folate levels in Mysore
were considerably higher than those reported in Western stud-
ies [30, 31]. A predominantly vegetarian diet among these
women, and a tendency to use high-dose folic acid supple-
ments throughout pregnancy, may explain this finding. The
prevalence of folate deficiency, though uncommon in all three
studies, was relatively higher among the Nepal women [9].
The prevalence of vitamin B12 deficiency (which was
extremely high in Pune) was high in all studies but
lowest in Nepal (27%). Surprisingly, the prevalence of
hyperhomocysteinaemia and mean homocysteine concentra-
tions were much lower in Mysore than in Pune and Nepal,
which had a similar prevalence. HOMA-IR values in Mysore
and Pune were similar, but lower in Nepal. In the Pune and
Nepal studies, it was the vitamin B12 status during early
pregnancy which was associated with offspring HOMA-IR;
however, there was no association with the late-gestation
concentrations, similar to the situation in Mysore. Both in
our study and in Pune, offspring HOMA-IR was associated
with maternal folate at 28 weeks’ gestation. While optimum
micronutrients during the early stages of pregnancy have
beneficial effects on fetal development, our findings suggest
that exposure to high folate levels in late pregnancy may
confer long-term metabolic risk.
The mechanism underlying our findings may be specula-
tive. There is evidence that the balance between folate and
vitamin B12 status is important for health. In an elderly
population in the USA, higher serum folate concentration
presumably due to higher intake, especially in the presence
of vitamin B12 deficiency, was associated with impaired
cognitive function and anaemia [32]. There is a suggestion
that the risk of cancer, cardiovascular disease and neuropsy-
chiatric disorders is increased at both high and low levels of
folate status [33]. Enzymes that require folate as a cofactor
may be inhibited by high levels of folate [34]. Higher folate in
our mothers may reflect higher dietary intake or the ‘folate
trap’ phenomenon, considering the low vitamin B12 status. In
B12 deficiency, the activity of vitamin B12-dependent methi-
onine synthase is reduced and cellular folate is trapped as
inactive 5-methyltetrahydrofolate, which may leak into plas-
ma, thus elevating serum folate levels [35, 36]. Impaired
methionine synthesis from homocysteine, and thus protein
synthesis, may hinder lean tissue deposition. There may also
be effects on DNA synthesis or on DNAmethylation that may
have long-term effects on gene expression and metabolism
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[36, 37]. The accumulation of homocysteine in the body may
also have adverse outcomes.
Our data do not give definitive evidence for the folate trap
as a mechanism: first, because there was no interaction be-
tween maternal folate and vitamin B12 in relation to the
child’s insulin resistance (the association between maternal
folate and insulin resistance in the child was not restricted to
children of B12-deficient mothers); and, second, because the
inverse association between folate and homocysteine was
mainly in mothers with low folate concentrations (ESM
Fig. 1). The Pune study findings did not support the folate
trap either [8]: although there was an interaction between
folate and vitamin B12, the folate measurement in Pune was
erythrocyte folate, which does not increase in the folate trap.
The folate trap mechanism therefore seems unlikely, though it
cannot be ruled out from the type of data that we have.
Maternal homocysteine level was relatively low despite a high
prevalence of B12 deficiency, which may be related to the
action of other B vitamins, such as vitamin B2 and B6, and
proteins on homocysteine conversion [23].
In our study the association between maternal folate and
offspring HOMA-IR was not present at 5 years of age, but
emerged at 9.5 years and persisted through to 13.5 years of
age. We have previously shown that the association between
maternal vitamin D deficiency [38] and glucose intolerance
[11, 14] with offspring HOMA-IR was present at 9.5 years of
age, but not at 5 years of age. At younger ages, high beta cell
activity in children may mask the insulin resistance.
Our study, taken together with the other studies from India
and Nepal, suggests that the folate–vitamin B12–homocyste-
ine pathway may have a role in regulating fetal growth and in
the intrauterine programming of later diabetes. The ‘proof of
principle’ for this comes from animal studies showing that
folate and other methyl donor nutrients in the maternal diet
influence adiposity and insulin resistance in the adult off-
spring and that this is associated with epigenetic changes,
for example altered DNA methylation [37, 39]. The initial
findings from human studies are complex, and more data,
especially from randomised trials of folate and/or vitamin
B12 in pregnancy, would be helpful.
A major strength of our study was the measurement of
circulating maternal nutrients during pregnancy, which is a
more robust indicator of maternal nutritional status than die-
tary or supplement intake levels. Detailed neonatal and child-
hood anthropometry, and measurement of an array of cardio-
vascular risk factors were other strengths. Offspring outcomes
were available at three time points during childhood and early
adolescence, which allowed us to examine whether the ob-
served associations were persistent. The plasma samples had
been stored for 8 years before analysing maternal nutrients.
These nutrients are thought to be stable over long periods,
however, when frozen at −80°C [40]. A comprehensive range
of measurements both during pregnancy in the mother and
later follow-up in the offspring enabled relevant adjustments.
It is likely that plasma folate levels were influenced by folic
acid supplements. Unfortunately, we did not collect data on
supplement use at 30 weeks’ gestation when maternal folate
status was measured. Supplementation could confound the
association between maternal folate concentrations and insu-
lin resistance in the child. For example, if mothers of higher
SES took more supplements, their children could also have
higher insulin resistance because of greater adiposity. The
association was unchanged, however, by adjusting for mater-
nal SES and the child’s BMI.
In conclusion, our study replicates the Pune finding of
higher insulin resistance in children born to mothers with
higher gestational folate levels. It also showed that this asso-
ciation persists through childhood into adolescence. We did
not see an association with maternal vitamin B12 status. In the
context of other studies, our study suggests that a deranged
maternal one-carbon pathway relates to impaired fetal growth
and cardiometabolic risks in later life. These are novel asso-
ciations which may help to elucidate the complexmechanisms
underlying the development of type 2 diabetes. These findings
are suggestive of ‘nutrient-mediated teratogenesis’, where
micronutrient deficiencies during intrauterine development
promote increased risks in the offspring [41], captured under
the broad ambit of developmental origins of health and dis-
ease. It is not clear whether these small changes observed in
relation to maternal B vitamins represent an increased risk of
later disease. Follow-up of children in different cohorts and
randomised controlled trials could help clarify these issues.
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